This test is most useful if any of these apply to you.
Dopamine is the brain chemical behind motivation, movement, reward, and focus. Your body does not measure dopamine directly in urine, but it leaves behind a trail of breakdown products, and the relationship between two of them carries hints about how that processing is happening.
This is a research-stage measurement without standardized clinical cutpoints, but it can give you a starting reference for tracking dopamine-related metabolism over time. Treat it as one piece of a broader picture rather than a verdict on any single condition.
After your body uses dopamine, it breaks it down into smaller pieces. Two of the main pieces are DOPAC (3,4-dihydroxyphenylacetic acid) and HVA (homovanillic acid). DOPAC forms inside dopamine-producing nerve cells through an enzyme called monoamine oxidase (a protein that breaks down brain chemicals), so it sits closer to where dopamine actually does its work. HVA is one step further downstream, made when another enzyme called catechol-O-methyltransferase (which adds a chemical tag that helps clear dopamine away) acts on DOPAC or dopamine in surrounding cells.
In human brain tissue and the fluid bathing the brain, HVA is the dominant dopamine breakdown product, with DOPAC present at a fraction of HVA levels. The ratio between the two reflects, in theory, how much dopamine is being processed close to its source versus how much continues through the longer downstream pathway.
Most published research on HVA and DOPAC uses spinal fluid, plasma, or brain tissue rather than urine. Studies in those matrices show that DOPAC tracks dopamine turnover inside nerve cells more closely, while HVA reflects broader systemic dopamine metabolism affected by enzyme activity outside neurons. A higher HVA share relative to DOPAC suggests a stronger pull through the downstream pathway, while a higher DOPAC share suggests more activity closer to the dopamine-producing cells.
Whether the same logic applies cleanly to a urine sample has not been confirmed in published clinical trials. Urinary HVA and DOPAC also come from sources outside the brain, including diet and gut microbes, which means the urinary ratio carries signal from multiple places at once.
Parkinson's disease is the clearest example of disrupted dopamine biology. Studies measuring spinal fluid (a related but different specimen) found that dopamine levels decline as the disease progresses, while ratios of HVA and DOPAC to dopamine shift over time, reflecting changing turnover in surviving nerve cells. In people taking levodopa, the standard Parkinson's medication, urinary HVA and DOPAC both rise substantially because the body converts levodopa into dopamine and then breaks it down through these same pathways.
A pilot study in Parkinson's patients found elevated urinary HVA compared with controls and proposed it as a non-invasive marker of treatment response. The ratio itself was not the focus of that work, but the underlying biology suggests that shifts in either component can reflect real changes in dopamine handling.
In a study of 137 first-diagnosed, drug-naive people with depression, combined dopamine turnover measures including DOPAC and HVA were linked to symptom severity. A separate observational study used urinary neurotransmitter metabolites to objectively screen workers for mental stress, finding patterns that distinguished those reporting higher psychological strain. The clinical use of an HVA/DOPAC urine ratio in these settings is still exploratory rather than established.
Your gut bacteria and the polyphenols in your diet, particularly from olives and olive oil, generate HVA and DOPAC outside the brain. A study of 60 people with functional constipation found that imbalanced dopamine and serotonin metabolite secretion in urine was tied to changes in the gut microbiome and to symptom severity. This is one reason a urinary ratio is not a pure brain readout. What you eat and the bacteria you carry both leave fingerprints on the result.
A prospective study of 1,618 people in the European EPIC cohort found that higher plasma HVA was associated with greater colon cancer risk. The signal came from plasma, not urine, and from HVA alone rather than the ratio, but it shows that this metabolite carries information beyond just brain chemistry. Separately, urinary HVA and a related metabolite called VMA have a long history in pediatric oncology as part of the diagnostic workup for neuroblastoma, a dopamine-producing tumor.
Absolute levels of HVA and DOPAC swing widely with diet, hydration, kidney clearance, and the specific gravity of any given urine sample. A ratio cancels out some of that noise because both molecules are measured in the same sample under the same conditions. What you are left with is the relative balance between the two breakdown pathways, which is more biologically meaningful than either number alone.
The trade-off is that a ratio can stay stable even when both numbers move, hiding genuine changes in dopamine activity. Pair the ratio with the individual values for a more complete picture.
Because this measurement has no universally agreed cutpoints and biological variability is high, a single reading tells you almost nothing on its own. The value comes from establishing your personal baseline and watching how it moves. Get a first measurement now, retest in 3 to 6 months if you are making changes to diet, stress management, or any dopamine-related therapy, and then check in at least annually.
Your trend is your own data. If your ratio moves in a meaningful direction over multiple readings, that is more actionable than comparing your single value to anyone else's reference range.
A surprising ratio on its own is not a diagnosis. The most useful next step is to repeat the test under controlled conditions: a consistent diet for several days beforehand, avoiding polyphenol-rich foods if you want a cleaner reading, and collecting at the same time of day. If the pattern holds, look at related urinary organic acids and catecholamine metabolites to put the result in context.
If you have symptoms that point toward Parkinson's disease, mood disorders, or gut-related issues, this marker is best interpreted alongside a clinician familiar with neurochemistry, such as a neurologist or a functional medicine practitioner. It is not a substitute for clinical evaluation, but it can be a useful conversation starter when paired with how you are actually feeling.
Evidence-backed interventions that affect your HVA / DOPAC Ratio level
HVA / DOPAC Ratio is best interpreted alongside these tests.
HVA / DOPAC Ratio is included in these pre-built panels.